Witness the immersive experience of Cannabis trade shows, retail summits, awards functions along with high-intensity networking among the veterans and global dignitaries of the cannabis business in Canada at the International Centre, Toronto, Canada. Cannabis enthusiasts, traders, researchers, and activists are invited to attend the 2-day O’Cannabiz Conference Expo & Awards from June 1-3rd 2022. Budding entrepreneurs can leverage this phenomenal stage where influential industry stalwarts will grace the occasion with their presence. Get valuable tips and learn the intricate strategies of the trade from Steve De Angelo, the father of the legal cannabis industry in his keynote address to the audience. Steve De Angelo along with Tommy Chong will be felicitated with lifetime achievement awards where attendees can witness the honors live in person. The O’Cannabiz event offers tremendous networking scope across the length and breadth of the global as well as Canadian audience. Newbies can connect with influencers and reputed entities to learn and discuss the future of cannabis across different sectors in Canada. The role of cannabis, from non-psychedelic uses, healing debilitating mental conditions, drug development, clinical applications, and its creative impact, to name a few, is huge. This conference is a great networking medium where thought leaders and professionals can connect to build relationships and explore the latest innovations, regulations, retailing scope, and more. The team behind the Expo and Awards is an experienced group of professionals who organize several high-profile trade summits and have robust connections with the governments worldwide and in Canada. From panel discussions to keynotes on extraction and regulation, along with presentation booths where presenters can gain visibility among influencers and investors, this event houses everything a cannabis enthusiast will look out for. The O’Cannabiz Conference Expo & Awards will be held at the sprawling 50,000 sq. ft International Center hall-5. The event will be attended by 3,500+ attendees who will get a chance to be a part of 70+ interactive sessions, on a platform where 180+ industry leaders will share insights on cannabis trading, laws and regulations, Cannabis extraction & compliance in Canada, the emergence of Agtech in cannabis space, the scope and future of industries, and other such interesting topics. Attendees will be treated to a Red Carpet Royalty Cocktail Reception, along with dinner and an awards ceremony. Networking continues in the after-party session with exhibitors, sponsors, and delegates. To learn more, please visit https://ocannabiz.com/.

• Municipal governments as well as private business operations are looking for suitable solutions for preventing crime in order to stem the rising tide of violence in the nation
• Autonomous Security Robot (“ASR”) developer Knightscope is deploying a variety of public-friendly ASR models designed to discourage crime and provide evidence resulting from any criminal activity
• Knightscope’s ASR models can draw on technology with artificial intelligence capabilities designed to recognize facial features and license plate identifiers, among other things
• The ASR models operate 24/7, 365 days a year according to client needs, and the models have logged more than a million hours since 2015
• The technology is also now available for single, double and triple shifts to help clients improve security programs
• One of Knightscope’s most recent clients is a Missouri recycling plant concerned about thieves bent on taking automotive scrap metals to resell them

Nationwide concerns about incidents of mass violence have led to increasing efforts to prevent crime through social outreach programs, citizen patrols, technological vigilance and better lighting at night, among other measures. Minneapolis Mayor Jacob Frey’s recently announced strategy for using federal funds from last year’s Congressional COVID-19 relief stimulus act is an example of how communities are working to combat crime by minimizing the likelihood of it happening in the first place (https://ibn.fm/ZJn1b). Minneapolis has been a flashpoint for law enforcement reform since the murder of a black man by the city’s police two years ago, and a recent investigation of the department found a pattern of racial discrimination by officers stretching back at least a decade (https://ibn.fm/P3X0s). Coincidentally, nearly a decade has passed since autonomous security robot (“ASR”) developer Knightscope (NASDAQ: KSCP) began working on non-threatening solutions to help deter criminal incidents and provide evidence stemming from those that do occur to help bring about their resolution. The outcome of those efforts was Knightscope’s ASR models, which provide a variety of client-responsive capabilities in an appealing package designed to interact well with the public. The ASRs come in one stationary and two mobile models (one indoor and one outdoor) that are able to operate 24 hours a day seven days a week under Knightscope’s Machine-as-a-Service (“MaaS”) business platform that draws on artificial intelligence capabilities, computer vision, digital technology and hands-on security management interaction with the models (https://ibn.fm/oXC7c). The company’s annual subscription service for the ASRs, and their browser-based command center interface used by the client’s security managers, amounts to about $3 to $9 per hour, providing a competitive alternative to continuous security patrols by human personnel and a lesser risk of harm to personnel. Under the terms of the subscription, Knightscope assesses client needs and the terrain the ASRs will cover, delivers the appropriate technological solution, provides 24/7 support for any maintenance or service required, and upgrades the models whenever the company introduces software or hardware improvements. The Knightscope ASR sentries have logged well over a million hours of service since 2015 as new clients have opted to include the security robots in their operation plans. One of the most recent companies to adopt Knightscope’s solution is a fourth-generation recycling center in Missouri. The recycler intends to use Knightscope’s roving outdoor ASR model to protect the metals it deals with, such as catalytic converters and other auto parts that are highly sought by metal thieves, according to a news report (https://ibn.fm/hUd2d). “It’s expensive. This is a national security issue. It’s a public safety issue. It’s an economic issue,” former Houston and Austin (Texas) Police Chief Art Acevedo told the report. For more information about Knightscope (NASDAQ: KSCP), visit the company’s website at www.Knightscope.com and if you have a need for subscription service you may request a private demonstration of the technology at www.Knightscope.com/demo. NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

• The ViralWall(TM) is a revolutionary new air-purification device engineered for personal-space protection
• KNOS is exclusive national distributor of revolutionary device designed to be “weapon against all bacteria and viruses”
• Company is eyeing growing graphene market as it looks to develop, support disruptive manufacturing methods and graphene-based products

Kronos Advanced Technologies (OTC: KNOS) has announced distribution of a revolutionary new air-purification device engineered for personal-space protection (https://ibn.fm/AWNSb). The ViralWall(TM) is designed to be placed between individuals, draw in their exhaled air, kill or disable pathogens as they move through the patented graphene-based air filter, and then release disinfected pathogen-free air. The first-ever self-sterilizing graphene air purifier on the market, the ViralWall was developed by Israel-based R&D company LIGC Application Ltd. “In the absence of better filtration technology, the indoor spaces where we spend most of our ‘normal’ life — schools, stores and workplaces — due to COVID-19, presented a real risk,” stated LIGC cofounder and CEO Yehuda Borenstein. “Our technology will provide cleaner and more breathable air with lower energy and maintenance costs and virtually silent sound levels. We are very pleased that Kronos has agreed to distribute our advanced technology and products in the USA.” Becoming the exclusive national distributor of this innovative device aligns with the focus of Kronos Advanced Technologies, a company committed to changing the way indoor air is filtered and disinfected. According to the company’s distribution announcement, “the device will act as a weapon against all bacteria and viruses, including antibiotic-resistant ‘superbugs,’ so its uses will extend well beyond the end of the pandemic. “The technology for this device grew out of a partnership between research groups at Rice University, Houston, Texas, and at the Zuckerberg Institute for Water Research, Ben-Gurion University of the Negev (‘BGU’), Israel,” the announcement continued. “Both teams were working on graphene-related projects. Often described as a ‘super material,’ a graphene is a form of carbon that measures just one atom thick. It is the thinnest and strongest material known and is flexible, transparent and highly conductive of both electricity and heat.” During the research, the Rice University developers determined that they could make a flexible air filter from porous and conductive graphene foam, called laser-induced graphene or LIG; in addition, they discovered that when they added small electrical pulses, the filter could kill airborne pathogens. These realizations led to the creation of the graphene-based ViralWall. “The graphene air filters will be more efficient, cost-effective, consume less energy, and require far less maintenance than other air filters currently on the market,” said Kronos CEO Michael Rubinov. The global graphene market was estimated at more than $94.4 million in 2020, with GrandView Research projecting it would grow at a compound annual growth rate (“CAGR”) of 43.2% from 2021 to 2028. KNOS is eyeing that growing market as it looks to develop and support disruptive manufacturing methods and graphene-based futuristic products today. Its distribution agreement with LIGC supports that strategy. LIGC has developed and owns a patented portfolio of revolutionary technologies for manufacturing processes to produce high-quality, low-cost 3D graphene. This graphene can be used in an array of applications, including air and water purification, biosensors, energy storage, and others. KNOS anticipates making many LIG offerings at its electronics manufacturing facility in West Virginia. Kronos is focused on next-generation, wellness consumer-electronics products and PPE solutions. Originally founded in 2002 and funded by the U.S. military to develop electrostatic air movers, KNOS has since evolved into the consumer air-purification space, initially focusing on developing, marketing and selling its proprietary air movement and purification technology. Proprietary KNOS technology is now also being implemented in multiple standalone products for businesses, homes and vehicles of all types to move, sterilize and filter air. Kronos Advanced Technologies is exploring broad ranges of additional markets for standalone and embedded Kronos CORE technology-based devices, including schools, universities, healthcare facilities, operating rooms, manufacturing clean rooms, automobile and commercial aircraft cabins, and specialized air filters for bitcoin-mining farms. For more information, visit the company’s website at www.KronosATI.co. NOTE TO INVESTORS: The latest news and updates relating to KNOS are available in the company’s newsroom at https://ibn.fm/KNOS

• In January 2022, Friendable Inc. and its Fan Pass Live artist platform completed the acquisition of Artist Republik (including FeaturedX), creating the first 360 artist offering available to independent artists who desire total control of their music
• All efforts made since the acquisition have led to visible key indicators of growth and scale as reported by stripe merchant reporting – including revenue per subscriber, spend per customer, and subscriber lifetime value
• CEO Robert A. Rositano Jr. expressed admiration for his team, having only launched Fan Pass Live in 2020, and now seeing remarkable growth across the industry as the first 360 platform artist offering

Since acquiring Artist Republik (including FeaturedX) in January 2022, Friendable (OTC: FDBL) has seen consistent growth across all facets of the business. The company has recently reported on its first 100 days of growth for its 360 artist platform offering, with a lot of the increase in numbers being closely attributed to Friendable’s Fan Pass Live artist platform taking the Artist Republik brand under its wing and successfully upgrading systems, rebuilding technologies, migrating/consolidating support, cross-promoting the entire 360 artist offering, and integrating brand messaging (https://ibn.fm/JjgqF). The company’s efforts have led to visible key indicators of growth and scale, allowing the focus to be on its delivery of targeted marketing messaging, industry word of mouth, and other forms of awareness that have led artists to Friendable’s Fan Pass Live artist platform offering. The key metrics being reported for Artist Republik during the first 100 days of 2022 include: January 4, 2022 – April 21, 2022 (source: stripe merchant reporting)

• Revenue per Subscriber – up 107.3% (an average of $10.72 per subscriber)
• Spend per Customer – up 28.3% (an average of $34.12 per customer)
• Subscriber LTV (Lifetime Value) – up 168.5% (an average Lifetime Value of $214.45)

“The reward of seeing results continues to motivate and point our team in the right direction, as our collective efforts of testing, iterating, testing, testing, and more testing pay off. We must constantly look at the macro vision and direction, but it’s the micro-levels of detail that provide the most valuable data as we seek the next milestones in artist sign-ups, fan engagement, and conversions to purchases of all kinds which is what the above results are showing us,” Friendable CEO Robert A. Rositano Jr. stated. He went on to explain that the company continues to be on the correct path, doing everything at a pace the business can keep up with, as it continues to explore new avenues and opportunities for explosive growth. “I can’t say it enough, but without our talented team internally and all of our partners, we would certainly never have made it to this place; it’s sometimes hard to believe how far we have come with the launch of our first artist offering less than 20 months ago, an acquisition just over three months ago, and the team continues to move through each challenge and deliver an amazing product with an unmatched level of support, and that’s not coming from me, this is straight from the artists and reviews being received by the Company,” Rositano Jr. added. “Thank you once again to my partner, brother, and CTO, Dean Rositano, our team, our partners, and our shareholders; 2022 has only just begun.” The Fan Pass Live app is available on Google Play and Apple. Alternately, users can visit www.FanPassLive.com to sign up for the 7-day free trial, which provides an all-access VIP experience and is only $2.99 per month after the initial trial. Artists also receive revenue (up to 40%) from these subscriptions. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

The year 2022 promises new business alliances in the cannabis trade ecosystem. Bearing testament to this global phenomenon, Lift&Co. Expo 2022, Canada’s No. 1 cannabis conference and trade show, is being held at the Metro Toronto Convention Centre from May 12-15, 2022. Global thought leaders, innovators, traders, and regulators of the cannabis ecosystem will assemble at the event to discuss, discover, and educate, surrounding the latest developments in this industry. Cannabis companies and budding entrepreneurs are invited to participate in the event, which includes the new CannaVest North Investment Forum, designed to connect aspiring companies with potential investors. CannaVest North will take place May 13-14 within the broader dates of the full Lift&Co. Expo. The event also offers access to a wide knowledge base on the current cannabis legislation and regulatory framework. Eminent leaders of the cannabis space will offer insights on how to build a consumer base and nurture engagement, as well as raise capital to take businesses to the next level. Educational opportunities include the Lift Cannabis Business Conference on May 12, as well as a wide array of speakers and panels throughout the expo dates of May 13-15. Young companies can showcase their products, services and creative ideas in the expo hall, as well. Hosting a booth at Lift&Co. Expo is the ideal entry point to connect with industry members, retailers, consumers, and patients, and develop key networking ties. All told, Lift&Co. Expo is a spectacular opportunity for cannabis businesses of all sizes and categories. Participants can share their knowledge as speakers or panelists, and partnership packages and exhibit spaces are also available for sale for those who seek to market their brand to this covetable audience. Attendees can leverage the expo to its full potential by making the most of the Industry Days, May 13-14, that offer networking among 1000s attendees and exhibitors. Join hands with peers and discover new brands from the 250+ exhibitors at Lift&Co. Expo Toronto 2022. To learn more, please visit https://liftexpo.ca/.

• Prime Harvest is leveraging a long-term strategy of investing in the growth and scale of licensed assets in California, anchored by the power of data-driven technology
• Its flagship brand, Jaxx Cannabis, aims to use technology to facilitate a true customer-centric culture while enhancing the overall craft cannabis experience
• The company is committed to the goal of creating a more sustainable environment, now and in the future
• Prime Harvest is a proud member of the Community Alliance Program, a foundation that seeks to make a difference in local communities
• The company’s leadership team boasts over 100 years of combined hands-on experience in cannabis genetics, cultivation, extraction, production, retail, marketing, regulation and consumer market development

Prime Harvest, based in San Diego, California, is a technology-focused, full-service cannabis company with horizontally diversified operations spanning various segments of the cannabis value chain, from licensing acquisition and compliance management to direct-to-consumer operations. The company is leveraging a long-term strategy of investing in the growth and scale of licensed assets anchored by the power of data-driven technology to expand its footprint throughout California. Sustainability is key to Prime Harvest’s corporate vision. The company aims to ensure that the communities it serves capture their fair share of the fruits of the industry’s growth, including financial profit, employment opportunities, environmental enrichment and impactful innovation through R&D and education. The company’s mission is to appeal to the ethos of the cannabis consumer by setting a new operational standard emphasizing accountability, sustainability and community. With this commitment, Prime Harvest continues to work toward positively affecting millions of lives through the creation of a world-class platform that caters to strengthening the commercial cannabis pipeline. Jaxx Cannabis Jaxx Cannabis is the flagship brand in Prime Harvest’s portfolio. Through Jaxx Cannabis, the company aims to use technology to facilitate a true customer-centric culture while enhancing the overall craft cannabis experience. Jaxx features an expertly curated selection of premium products from some of the most respected brands in the thriving California market. Key values serving as the foundation of Jaxx Cannabis include:

• Creating and nurturing a welcoming culture for all
• Unlocking the true potential of customer value
• Being innovative in uncovering new ways to grow both the company and the industry
• Meeting the wants and needs of consumers to promote profitability
• Remaining accountable for the results of its operations

It is these values that differentiate Prime Harvest and Jaxx Cannabis in the California cannabis sector. Brand Partnerships Prime Harvest works diligently to establish strong alliances with complementary brands that are in alignment with its culture and values. Through a combination of deliberate foresight and strategic action, the company seeks to grow existing cannabis brands and continuously discover new, high-potential performers that are primed for long-term success. These partnerships enhance Prime Harvest’s efforts to transform the world’s cannabis access and bring its consumers high-quality products that are fair for both people and the planet. Responsibility Prime Harvest remains committed to the goal of creating a more sustainable environment, now and in the future. Concern for human beings and the environment can be observed in every facet of its operations, including its ongoing R&D activities dedicated to exploring methods of reducing and repurposing waste into composite materials and exploring the potential of the hemp plant for industrial and wellness contributions. The company is a proud member of the Community Alliance Program, a foundation that seeks to make a difference in local communities by providing financial assistance for educational programs, housing homeless veterans, creating urban farms, and holding local arts initiatives for children and adults. The program also helps explore the natural healing attributes of medical cannabis through research, development, clinical trials, and advocating for the safe access of cannabis to those in need. Market Overview Ongoing changes in U.S. state government policies toward cannabis are expected to cause demand for legal marijuana to surge. In addition, the number of indications for which medical marijuana is prescribed continues to increase. These factors are expected to rapidly boost legal sales of cannabis products. Legal sales across the U.S. hit a record of $17.5 billion in 2020, marking an increase of 46% over 2019, according to Forbes. This strong growth is expected to continue. According to a Grand View Research report, the global legal marijuana market is forecast to grow at a CAGR of 26.7 percent from 2021 to 2028. California – Prime Harvest’s home state – has consistently led the pack in terms of U.S. cannabis sales. The Motley Fool pegged cannabis spending in the Golden State at $3.8 billion in 2020, more than doubling the second state on its list. Leadership Team The Prime Harvest team is composed of true experts in their respective fields focused on building a world-class organization capable of driving the cannabis industry and movement forward. E. Duane Alexander is the company’s Founder and CEO. He brings to the team more than 25 years of real-world, hands-on cannabis retail, marketing and commercial operations experience. Mr. Alexander has championed 40+ cannabis license applications throughout the western U.S. to date. John Wilczak is the COO of Prime Harvest. He has 30+ years of executive management, strategy development & configuration experience with GE, pharmaceutical and agriculture companies. Mr. Wilczak is a Brown & Columbia MBA with vast knowledge of technology driven intellectual properties. Andrea Jenson is the Chief Financial Officer of Prime Harvest. As CFO, she is responsible for all the company’s financial functions, including accounting, corporate finance and investor relations. Her career spans more than 20 years of varied experience in financial management, business leadership and financial strategy. John Kazanjian is the VP of Business Development of Prime Harvest. He has worked over 40 years in business operations, brand marketing, sales and investor/lender communications. Mr. Kazanjian earned his B.S. from Rutgers University and his MBA from Harvard University. Johann Balbuena is the Chief Marketing Officer of Prime Harvest. She has more than six years of experience in California cannabis licensing acquisition and compliance management. Ms. Balbuena has led multimedia production and content marketing efforts for the likes of the Social Club TV app, The Emerald Cup, High Times, Weedmaps and Synergy. For more information, visit the company’s website at NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest are available in the company’s newsroom at https://ibn.fm/PRIME

• Delic Holdings Corp was founded four years ago, devoted to making psychedelic drug therapies available to patients with hard-to-treat mental and emotional conditions
• The company’s research arm has received authorization in Canada to work with substances such as psilocybin, MDMA (Ecstasy), LSD, DMT (Dimitri), mescaline and 2C-B
• In the United States, the company operates the country’s largest chain of ketamine (anesthesia-related medication) clinics for wellness therapies
• Delic Co-founder and CEO Matt Stang will continue his outreach to investors and other potential sources of industry financing when he presents an overview of the company’s operations and its outlook for the coming year at the annual Planet MicroCap Showcase in Las Vegas May 3-5

During the past decade, cannabis has shed much of its reputation as a patently illegal substance used by stoners, instead gaining some gravitas as a source for health and wellness benefits ranging from anxiety treatment to the first U.S. Food and Drug Administration (“FDA”)-approved cannabis-derived pharmaceutical for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome (https://ibn.fm/8ewej). On the coattails of cannabis research, psychedelics research is gaining legitimacy as medical innovators search for other solutions to largely intractable mental and emotional illnesses (https://ibn.fm/QGFB2). Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leader in new treatments and medicines for a modern world, has been helping to lead the charge in the development of psychedelic therapies that, in combination with oversight from mental health professionals, could help patients to obtain a better quality of life while dealing with post-traumatic stress disorder (“PTSD”), suicidality and chronic pain, among other concerns. The company will provide investors and financiers with updated information on its near-term strategy at an upcoming conference in Las Vegas. Delic Labs — the research facility that is the scientific development backbone of Delic Holdings’ ecosystem — recently received authorization in Canada to acquire 60 grams of psilocybin mushrooms for its research and authorization to do additional research with hallucinogenic compounds such as MDMA (Ecstasy), LSD, DMT (Dimitri), mescaline and 2C-B (https://ibn.fm/o4eos). In the United States, Delic Holdings operates the largest chain of mental health wellness clinics in the country providing ketamine (an anesthetic medication that produces a dissociative state) treatments to patients. The clinics currently offer the treatments via IV infusion and a related nasal spray branded Spravato based on the ketamine derivative esketamine. Delic Co-founder and CEO Matt Stang has been sharing the company’s outlook with investors and business colleagues in recent weeks, and the company announced April 28 that he will deliver a presentation that highlights the Company’s development and outlook for the second half of the year when entrepreneurs and finance dealmakers gather for the annual Planet MicroCap Showcase in Las Vegas May 3-5 (https://ibn.fm/UstVC). “This is a whole order of magnitude beyond cannabis,” Stang told Planet Microcap host SNN Network’s Robert Kraft in an interview published on YouTube ahead of the conference (https://ibn.fm/It1yS). “Cannabis is an incredible recreational substance. It’s safer than alcohol and cigarettes and should be totally legal and available for folks who want to take the edge off and not drink a chardonnay,” Stang added, also discussing his mother’s use of cannabis to obtain relief while undergoing chemotherapy. “When you look at psychedelics, what (they) can do is actually give people the ability to process trauma that is otherwise going to affect their ability to live a beneficial life. … I think there’s just a huge demand for this.” Stang noted that the company ended 2021 with an $8 million-plus run-rate and expects continued revenue growth through its clinics and research vehicles during the coming months. “People looking at psychedelics have looked at a bunch of air (from other companies) — there’s a bunch of ‘We’re going to do this in five years’ or ‘We’re going to do this in seven years.’ Well, we’re doing it today, and we’re going to make real money helping people,” he said. The company’s Planet MicroCap presentation is scheduled to take place May 4 at 2 p.m., local time. The registration portal and instructions are available at https://ibn.fm/5MjnD. For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

• Lexaria received its 25th patent – and the first patent for the use of DehydraTECH technology in the enhanced delivery of antiviral drugs
• The company is seeking IND approval from the FDA and has commenced its human HYPER-H21-4 study for hypertension with DehydraTECH-CBD, with results expected in Q3 2022
• Lexaria is also commencing its human oral nicotine study, NIC-H22-1 to compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing leading brands currently sold in the US such as ON! and Zyn

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has announced some positive news that further promotes the company’s goal of creating innovative drug delivery alternatives with its proprietary patented DehydraTECH(TM) technology. Lexaria is making the delivery of drugs quicker, more efficient, and even tasting better. The company was granted its 25th patent – the first received for the use of its DehydraTECH technology for the enhanced delivery of antiviral drugs. The official word was received from the United States Patent and Trademark Office that on April 26, 2022, patent 11,311,559 for Compositions and Methods For Enhanced Delivery of Antiviral Agents would be issued to Lexaria. “This will be our 25th patent granted worldwide and another validation of the versatility of our DehydraTECH drug delivery technology. This new patent adds to our existing suite of granted patents in the EU, the U.S., India, Japan, and Australia, and continues to build value for Lexaria shareholders and clients,” CEO Chris Bunka explained (https://ibn.fm/wksKc). Lexaria is also working on various clinical trial studies, including the recently announced HYPER-H21-4 study. HYPER-H21-4 is a randomized, double-blinded, placebo-controlled, cross-over study in 60 people and also one of the most comprehensive studies taken on by the company. Outcomes for the new study are expected to be available in Q3 2022, and the research is a big step for the company seeking IND (investigational New Drug) approval from the FDA. Moving forward with the HYPER-H21-4 study was motivated by positive findings in the company’s three other human hypertension clinical studies, which has further supported the pursuit of FDA approval. The studies conducted thus far with hypertension and DehydraTECH have yielded positive results in terms of safety and efficacy (https://ibn.fm/1wSSL) as well as reducing blood pressure (https://ibn.fm/nYrS7) and arterial stiffness (https://ibn.fm/lKalR). All of the past study participants have tolerated DehydraTECH-CBD well, with no adverse effects. Additionally, Lexaria plans to move forward in dosing for their human NIC-H22-1 study this summer. The study is focused on the oral absorption of nicotine and the comparison will be made between the company’s DehydraTECH-nicotine pouch and other popular products on the market like Zyn and ON! The purpose of the study is to support a safe alternative to harmful pulmonary nicotine application processes. The company’s DehydraTECH technology works to:

• Speed up drug delivery
• Increase bioavailability
• Increase brain absorption
• Improves drug potency
• Reduce drug administration costs
• Mask unwanted tastes

The company has been advancing its technology since 2016 to demonstrate that bio-absorption of drugs like cannabinoids or nicotine can be five to ten times more effective with a reduced onset time. Lexaria also plans to investigate other markets in 2022 (https://ibn.fm/O4zMN). For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Contest recognized companies that show “deep insight” into new market fundamentals
• Nowigence one of 10 finalists invited to deliver final pitches to industry experts
• Nowigence emerging in the AI software space as a top contender with its proprietary offering, Pluaris

Last year, KPMG Private Enterprise announced its Global Tech Innovator competition. Nowigence Inc. (NOWG) was named as one of the finalists in the contest, which was designed to identify leading tech innovators in the United States that have the potential to become the next tech titans on the global stage. “The world has changed,” states KPMG Private’ website (https://ibn.fm/imMLB). “Thriving in today’s dynamic marketplace requires deep insight into the new market fundamentals. And it takes a clear understanding of the rapidly evolving regulatory and tax landscape, investor trends, supply and demand disruptions, and changing customer expectations. KPMG Private Enterprise advisers understand the trends influencing the new reality and are hard at work helping private companies uncover and capture new opportunities in their markets.” As part of that quest, KPMG launched its Global Tech Innovator competition. “Nearly 80 companies applied for the chance to be crowned the KPMG Private Enterprise Tech Innovator in the U.S.,” the company reported (https://ibn.fm/Ct5rw). The company noted that 10 finalists were invited to deliver their final pitches to a panel of industry experts. Nowigence Inc. was one of those companies. Nowigence is emerging in the AI software space as a top innovative contender with its proprietary offering, Pluaris. The comprehensive, ready-to-use AI platform works around the clock to read and analyze relevant content as it is released in various public and private data sources (https://ibn.fm/vEbJN). Topics can be customized by users, based on subjects they are interested in or required to be informed about because of their job tasks or other responsibilities. Pluaris opens relevant files stored in tools and databases with which it is integrated. It uses machine learning (“ML”) and natural language processing (“NLP”) techniques to analyze the content. This data is then transformed, linked, taxonomized and optimized for storage, analysis, synthesis and retrieval. In addition, this game-changing app can provide precise answers to questions, analyze different perspectives, discover new connections, and create organized and nested notes. Thanks to Pluaris, teams can work collaboratively from anywhere in the world to share and draw informed conclusions. Nowigence’s Pluaris offering provides a unique solution to the growing challenge of collaboration overload and the desperate need for tools that identify, organize and distribute information in a uniform way so that everyone has access to critical information. Pluaris reads and analyzes articles, documents and other textual data so that users can learn more in less time, uncover hidden insights and stay on top of the information they need to know. By integrating state-of-the-art data-processing techniques in an intuitive interface at an affordable subscription price, Pluaris allows and supports collaboration in the most efficient and effective way possible. For more information, visit the company’s website at www.Nowigence.com. NOTE TO INVESTORS: The latest news and updates relating to Nowigence are available in the company’s newsroom at https://ibn.fm/NOW

• Red White & Bloom Brands is a multi-state cannabis operator based in Canada and focused on developing revenue opportunities in strong U.S. cannabis markets such as Michigan, Florida and California
• The company recently announced it has eliminated $115 million in debt liabilities as part of its efforts to streamline its financial operations during a period when many companies are struggling with the effects of the COVID pandemic
• Red White & Bloom’s debt reduction includes cutting over $22 million in annual expenses
• The company has solidified its foothold in Michigan with acquisitions that have allowed it to become vertically integrated and open new dispensaries and cultivation facilities

Multi-state cannabis operator Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is making new strides in streamlining its operations as the company accelerates its push toward making its popular Platinum Vape-branded products some of the most recognizable premium cannabis products in the United States. Red White & Bloom, or RWB, has been strengthening its revenue streams in the states where it operates, particularly in Michigan, Florida and California of late, while also working to deal with its debt to make it more long-term feasible, announcing April 20 that it has eliminated several million dollars’ worth of liabilities and annual expenses (https://ibn.fm/Du1gj). The acquisition earlier this year of a 15,000-square-foot manufacturing, processing and distribution facility as well as properties owned by PharmaCo, Inc., in Michigan, plus full licensing for manufacturing both medical and adult use cannabis products in the state, assured RWB’s efforts to become fully vertically integrated and to expand the reach of Platinum Vape. Platinum Vape products not only include carefully crafted vape cartridges and disposable vape pens, but also gummies, chocolates and premium cannabis flower. New data published on the Canadian Federation of Independent Business (“CFIB”)’s Small Business Recovery Dashboard is shining a light on the difficulties SBEs are facing in Canada in the wake of the COVID pandemic and the “staggering level of fresh COVID-related debt small firms have had to take on” as a result of the pandemic’s battering of economies worldwide. “Two-thirds of small businesses (65%) have had to take on debt, at an average of $160,000, just to survive the past two-years,” CFIB president Dan Kelly stated in a news release about the survey results (https://ibn.fm/5OqDt). “For almost 900,000 business owners, up to $60,000 of this debt is in the form of a government-backed Canada Emergency Business Account loan. … The 2022 budget missed an opportunity to forgive a larger portion of these loans for the most deeply affected small businesses.” Vancouver, British Columbia-based RWB’s April 20 announcement notes that the company expects to eliminate an intangible asset of about $77 million as well as a license liability of $60 million from its balance sheets following restructuring of its debt while reducing “well over $100 million of liabilities without any dilution to our shareholders,” a continuation of efforts since last year to cut debt. As part of the restructuring, RWB pruned its Illinois property, exiting “the one state that had not contributed any revenue from THC operations to our results since our inception,” CEO Brad Rogers stated. “We still believe that Illinois could be a great market for us, and will look to pursue it from an asset-light approach through licensing of our own brands,” Rogers added. “We will continue to look for opportunities to grow our revenue through a number of asset-light entries to other states, while focusing on getting to a positive adjusted EBITDA run-rate by the end of 2022.” The company has also found ways to reduce its headcount as part of the effort, joining other SBEs in a revived trend to control their cash consumption and attract new capital through minimal staffing adjustments (https://ibn.fm/E50Th). “We are very pleased with the significant balance sheet and operational improvements we have made in a relatively short period of time. Today’s announcement is the culmination of an in-depth review and rationalization of assets and operations,” Rogers stated. For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF